Your shopping cart is currently empty

dA-NHbenzylOCF3 is a DNA-targeting radiosensitizer that enhances tumor cell sensitivity to X-rays via the dissociative electron attachment (DEA) mechanism. It exhibits low toxicity to normal cells and primarily localizes in the cytoplasm and nucleus after cellular entry. The compound induces radiosensitization by causing cell cycle arrest at the G2/M phase, which is sensitive to radiation. dA-NHbenzylOCF3 is applicable in research on radiosensitization for malignant tumors such as prostate and breast cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | dA-NHbenzylOCF3 is a DNA-targeting radiosensitizer that enhances tumor cell sensitivity to X-rays via the dissociative electron attachment (DEA) mechanism. It exhibits low toxicity to normal cells and primarily localizes in the cytoplasm and nucleus after cellular entry. The compound induces radiosensitization by causing cell cycle arrest at the G2/M phase, which is sensitive to radiation. dA-NHbenzylOCF3 is applicable in research on radiosensitization for malignant tumors such as prostate and breast cancer. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.